The methylation of RARB and RASSF1A genes appears to be an initial event in urinary bladder carcinogenesis maintained during tumor progression and should be included in the panels of differentially methylated genes in urinary bladder cancer in order to maximize the diagnostic coverage of epigenetic markers. Here, RASSF1 is linked to urinary bladder cancer.